scholarly journals Differential Expression Profiles and Functional Prediction of Circular RNAs and Long Non-coding RNAs in the Hippocampus of Nrf2-Knockout Mice

2019 ◽  
Vol 12 ◽  
Author(s):  
Run-Jiao Zhang ◽  
Yan Li ◽  
Qing Liu ◽  
Yan-Jing Gao ◽  
Juan Du ◽  
...  
Keyword(s):  
Differential Expression ◽  
Knockout Mice ◽  
Expression Profiles ◽  
Circular Rnas ◽  
Functional Prediction ◽  
Nrf2 Knockout ◽  
Non Coding Rnas

scholarly journals Differential expression profiles and functional analysis of circular RNAs in children with fulminant myocarditis

Epigenomics ◽  
2019 ◽  
Vol 11 (10) ◽  
pp. 1129-1141 ◽  
Author(s):  
Li Zhang ◽  
Bo Han ◽  
Jing Wang ◽  
Qingqing Liu ◽  
Yaru Kong ◽  
...  
Keyword(s):  
Functional Analysis ◽  
Healthy Volunteers ◽  
Differential Expression ◽  
Expression Profiles ◽  
Interaction Network ◽  
Fulminant Myocarditis ◽  
Circular Rnas ◽  
Biological Functions ◽  
Microarray Experiments ◽  
Network Building

Aim: To assess differential expression profiles of circular RNAs (circRNAs) and explore their possible functions in children with fulminant myocarditis. Materials & methods: circRNA microarray experiments were carried out for determining differential expression profiles of circRNAs in three children with fulminant myocarditis and three healthy volunteers. Functional analysis and circRNA–miRNA–mRNA interaction network building were conducted to study biological functions. Results: This work identified 2281 upregulated and 892 downregulated circRNAs. Further assessment confirmed hsa_circ_0071542 upregulation (2.5-fold) in fulminant myocarditis. Functional analysis demonstrated the differentially expressed circRNAs mainly contributed to inflammation and immunity. Conclusion: circRNAs might have substantial roles in pediatric fulminant myocarditis, and hsa_circ_0071542 could serve as a promising biomarker.

scholarly journals Differential expression profiles of long non-coding RNAs reveal potential biomarkers for identification of human gastric cancer

2015 ◽  
Vol 35 (3) ◽  
pp. 1529-1540 ◽  
Author(s):  
CHENGYUN LI ◽  
GEYU LIANG ◽  
WENZHUO YAO ◽  
JING SUI ◽  
XIAN SHEN ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Differential Expression ◽  
Expression Profiles ◽  
Human Gastric Cancer ◽  
Non Coding Rnas ◽  
Potential Biomarkers

scholarly journals Distinct Expression Profiles of lncRNAs Between Regressive and Mature Scars

2015 ◽  
Vol 35 (2) ◽  
pp. 663-675 ◽  
Author(s):  
Jingyun Li ◽  
Wei Long ◽  
Qian Li ◽  
Qing Zhou ◽  
Yu Wang ◽  
...  
Keyword(s):  
Gene Ontology ◽  
Immune System ◽  
Differential Expression ◽  
Pathway Analysis ◽  
Expression Profiles ◽  
Molecular Targets ◽  
Differentially Expressed ◽  
Altered Expression ◽  
Qrt Pcr ◽  
Non Coding Rnas

Background: Recent studies suggest that long non-coding RNAs (lncRNAs) play crucial roles in human diseases. The function of lncRNAs in abnormal scar pathogenesis remains poorly understood. Methods: In this study, we examined the lncRNAs expression profiles among regressive and mature scars following caesarean sections. A total of 30,586 lncRNAs and 26,109 mRNAs were analyzed by microarrays (Human LncRNA Array v3.0, Arraystar, Inc.). Results: In total, we identified 1,871 lncRNAs and 817 mRNAs with differential expression between regressive and mature scar individuals (fold change≥3, p≤0.001). A set of differentially expressed lncRNA transcripts, in particular, lncRNA8975-1, AC097662.2 and RP11-586K2.1, were confirmed using qRT-PCR. Gene ontology and pathway analysis revealed that compared to mature scars, many processes over-represented in regressive scars are related to the immune system. Conclusion: Our results show significantly altered expression profiles of lncRNAs and mRNAs between regressive and mature scars. These transcripts are potential molecular targets for inhibiting abnormal scar formation following caesarean sections.

scholarly journals MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in Pheochromocytoma/Paraganglioma

Cancers ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 1522
Author(s):  
Peter Istvan Turai ◽  
Gábor Nyírő ◽  
Henriett Butz ◽  
Attila Patócs ◽  
Peter Igaz
Keyword(s):  
Expression Profiles ◽  
Treatment Options ◽  
Tumor Biology ◽  
Metastatic Potential ◽  
Circular Rnas ◽  
Ribonucleic Acids ◽  
Rna Molecules ◽  
Diagnostic Potential ◽  
Non Coding Rna ◽  
Non Coding Rnas

Around 40% of pheochromocytomas/paragangliomas (PPGL) harbor germline mutations, representing the highest heritability among human tumors. All PPGL have metastatic potential, but metastatic PPGL is overall rare. There is no available molecular marker for the metastatic potential of these tumors, and the diagnosis of metastatic PPGL can only be established if metastases are found at “extra-chromaffin” sites. In the era of precision medicine with individually targeted therapies and advanced care of patients, the treatment options for metastatic pheochromocytoma/paraganglioma are still limited. With this review we would like to nurture the idea of the quest for non-coding ribonucleic acids as an area to be further investigated in tumor biology. Non-coding RNA molecules encompassing microRNAs, long non-coding RNAs, and circular RNAs have been implicated in the pathogenesis of various tumors, and were also proposed as valuable diagnostic, prognostic factors, and even potential treatment targets. Given the fact that the pathogenesis of tumors including pheochromocytomas/paragangliomas is linked to epigenetic dysregulation, it is reasonable to conduct studies related to their epigenetic expression profiles and in this brief review we present a synopsis of currently available findings on the relevance of these molecules in these tumors highlighting their diagnostic potential.

scholarly journals CircRNAs as Potential Blood Biomarkers and Key Elements in Regulatory Networks in Gastric Cancer

2022 ◽  
Vol 23 (2) ◽  
pp. 650
Author(s):  
Laís Reis-das-Mercês ◽  
Tatiana Vinasco-Sandoval ◽  
Rafael Pompeu ◽  
Aline Cruz Ramos ◽  
Ana K. M. Anaissi ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Minimally Invasive ◽  
Regulatory Networks ◽  
Expression Profiles ◽  
Functional Enrichment ◽  
Circular Rnas ◽  
Rna Seq ◽  
Tissue Samples ◽  
Molecular Alterations ◽  
Non Coding Rnas

Gastric cancer (GC) is the fifth most common type of cancer and the third leading cause of cancer death in the world. It is a disease that encompasses a variety of molecular alterations, including in non-coding RNAs such as circular RNAs (circRNAs). In the present study, we investigated hsa_circ_0000211, hsa_circ_0000284, hsa_circ_0000524, hsa_circ_0001136 and hsa_circ_0004771 expression profiles using RT-qPCR in 71 gastric tissue samples from GC patients (tumor and tumor-adjacent samples) and volunteers without cancer. In order to investigate the suitability of circRNAs as minimally invasive biomarkers, we also evaluated their expression profile through RT-qPCR in peripheral blood samples from patients with and without GC (n = 41). We also investigated the predicted interactions between circRNA-miRNA-mRNA and circRNA-RBP using the KEGG and Reactome databases. Overall, our results showed that hsa_circ_0000211, hsa_circ_0000284 and hsa_circ_0004771 presented equivalent expression profiles when analyzed by different methods (RNA-Seq and RT-qPCR) and different types of samples (tissue and blood). Further, functional enrichment results identified important signaling pathways related to GC. Thus, our data support the consideration of circRNAs as new, minimally invasive biomarkers capable of aiding in the diagnosis of GC and with great potential to be applied in clinical practice.

scholarly journals Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: a review

Mutagenesis ◽  
2019 ◽  
Vol 35 (3) ◽  
pp. 243-260 ◽  
Author(s):  
Antonio Francavilla ◽  
Szimonetta Turoczi ◽  
Sonia Tarallo ◽  
Pavel Vodicka ◽  
Barbara Pardini ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Expression Profiles ◽  
Predictive Markers ◽  
Circular Rnas ◽  
Rna Molecules ◽  
Non Coding Rna ◽  
Non Coding Rnas ◽  
Prognostic And Predictive Markers

Abstract The circulating human transcriptome, which includes both coding and non-coding RNA (ncRNA) molecules, represents a rich source of potential biomarkers for colorectal cancer (CRC) that has only recently been explored. In particular, the release of RNA-containing extracellular vesicles (EVs), in a multitude of different in vitro cell systems and in a variety of body fluids, has attracted wide interest. The role of RNA species in EVs is still not fully understood, but their capacity to act as a form of distant communication between cells and their higher abundance in association with cancer demonstrated their relevance. In this review, we report the evidence from both in vitro and human studies on microRNAs (miRNAs) and other ncRNA profiles analysed in EVs in relation to CRC as diagnostic, prognostic and predictive markers. The studies so far highlighted that, in exosomes, the most studied category of EVs, several miRNAs are able to accurately discriminate CRC cases from controls as well as to describe the progression of the disease and its prognosis. Most of the time, the in vitro findings support the miRNA profiles detected in human exosomes. The expression profiles measured in exosomes and other EVs differ and, interestingly, there is a variability of expression also among different subsets of exosomes according to their proteic profile. On the other hand, evidence is still limited for what concerns exosome miRNAs as early diagnostic and predictive markers of treatment. Several other ncRNAs that are carried by exosomes, mostly long ncRNAs and circular RNAs, seem also to be dysregulated in CRC. Besides various technical challenges, such as the standardisation of EVs isolation methods and the optimisation of methodologies to characterise the whole spectrum of RNA molecules in exosomes, further studies are needed in order to elucidate their relevance as CRC markers.

scholarly journals Molecular interactions of miR-338 during tumor progression and metastasis

2021 ◽  
Vol 26 (1) ◽  
Author(s):  
Meysam Moghbeli
Keyword(s):  
Cell Proliferation ◽  
Tumor Progression ◽  
Signaling Pathways ◽  
Tumor Cells ◽  
Expression Profiles ◽  
Circular Rnas ◽  
Main Body ◽  
Specific Expression ◽  
Aberrant Expression ◽  
Non Coding Rnas

Abstract Background Cancer, as one of the main causes of human deaths, is currently a significant global health challenge. Since the majority of cancer-related deaths are associated with late diagnosis, it is necessary to develop minimally invasive early detection markers to manage and reduce mortality rates. MicroRNAs (miRNAs), as highly conserved non-coding RNAs, target the specific mRNAs which are involved in regulation of various fundamental cellular processes such as cell proliferation, death, and signaling pathways. MiRNAs can also be regulated by long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs). They are highly stable in body fluids and have tumor-specific expression profiles, which suggest their suitability as efficient non-invasive diagnostic and prognostic tumor markers. Aberrant expression of miR-338 has been widely reported in different cancers. It regulates cell proliferation, migration, angiogenesis, and apoptosis in tumor cells. Main body In the present review, we have summarized all miR-338 interactions with other non-coding RNAs (ncRNAs) and associated signaling pathways to clarify the role of miR-338 during tumor progression. Conclusions It was concluded that miR-338 mainly functions as a tumor suppressor in different cancers. There were also significant associations between miR-338 and other ncRNAs in tumor cells. Moreover, miR-338 has a pivotal role during tumor progression using the regulation of WNT, MAPK, and PI3K/AKT signaling pathways. This review highlights miR-338 as a pivotal ncRNA in biology of tumor cells.

Sign in / Sign up

Export Citation Format

Share Document